CORV News and Press, Correvio Pharma Corp. From 02/07/20

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that h...

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that h...

NASDAQ: CORV TSX: CORV VANCOUVER , Jan. 28, 2020 /PRNewswire/ - Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), ("Correvio" or the "Company") announced today that it has received two written notifications from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is ...

NEW YORK, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plainti...

Will These Penny Stocks Break to New Highs This Week? The stock market has been in breakout mode this week as the Santa Claus rally continued to push stocks higher on Thursday. The NASDAQ managed to break a new, all-time high and other markets around the world also saw big surges in trading mo...

Correvio Pharma (NASDAQ: CORV ) receives a complete response letter saying that the FDA can't approve the NDA for Brinavess in its present form. More news on: Correvio Pharma Corp., Healthcare stocks news, Stocks on the move, Read more ...

Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events Canada NewsWire VANCOUVER, Dec. 24, 2019 NASDAQ: CORV  TSX: CORV VANCOUVER , Dec. 24, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watc...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Correvio Pharma Corporation (“Correvio” or the “Company”) (NASDAQ: CORV ) investors concerning the Company and its officers’ possible violations of federal securit...